Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW)vsWest Pharmaceutical Services Inc (WST)
PSNYW
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
$5.33
+0.19%
CONSUMER CYCLICAL · Cap: $34.90B
WST
West Pharmaceutical Services Inc
$245.27
+1.60%
HEALTHCARE · Cap: $17.68B
Smart Verdict
WallStSmart Research — data-driven comparison
West Pharmaceutical Services Inc generates 21% more annual revenue ($3.07B vs $2.55B). WST leads profitability with a 16.1% profit margin vs -106.0%. WST earns a higher WallStSmart Score of 55/100 (C-).
PSNYW
Avoid34
out of 100
Grade: F
WST
Buy55
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for PSNYW.
Margin of Safety
-256.8%
Fair Value
$68.99
Current Price
$245.27
$176.28 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 26.1% year-over-year
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.6%
Areas to Watch
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
Premium valuation, high expectations priced in
2.1% earnings growth
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : PSNYW
The strongest argument for PSNYW centers on Revenue Growth. Revenue growth of 26.1% demonstrates continued momentum.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.
Bear Case : PSNYW
The primary concerns for PSNYW are EPS Growth, Return on Equity, Free Cash Flow.
Bear Case : WST
The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.
Key Dynamics to Monitor
PSNYW profiles as a growth stock while WST is a mature play — different risk/reward profiles.
PSNYW carries more volatility with a beta of 1.65 — expect wider price swings.
PSNYW is growing revenue faster at 26.1% — sustainability is the question.
WST generates stronger free cash flow (175M), providing more financial flexibility.
Bottom Line
WST scores higher overall (55/100 vs 34/100), backed by strong 16.1% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA
Polestar Automotive Holding UK PLC (Ticker: PSNYW) is a leading contender in the electric performance vehicle market, distinguished by its commitment to innovation and sustainability. As a subsidiary of Volvo Cars and Geely, Polestar leverages cutting-edge technology and engineering to create high-performance electric vehicles, exemplified by its flagship model, the Polestar 2, which integrates exceptional design with advanced connectivity features. The company is strategically enhancing its global presence and production capabilities, positioning itself to capitalize on the rapid growth of the electric vehicle sector and play a pivotal role in the transition towards a sustainable automotive future.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other AUTO MANUFACTURERS Stocks
Want to dig deeper into these stocks?